HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

NU-ICRF 505

an anthracenyl-amino acid conjugate; a topomerase I cleavage inducer; structure given in first source
Also Known As:
ICRF 505; NU 505; NU-ICRF-505
Networked: 6 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Cummings, Jeffrey: 3 articles (05/2006 - 02/2002)
2. Ethell, Brian T: 2 articles (05/2006 - 02/2002)
3. Burchell, Brian: 2 articles (05/2006 - 02/2002)
4. Smyth, John F: 2 articles (01/2004 - 02/2002)
5. Jodrell, Duncan I: 2 articles (01/2004 - 02/2002)
6. Boyd, Gary: 2 articles (01/2004 - 02/2002)
7. Jardine, Lesley: 1 article (05/2006)
8. Maliepaard, Mark: 1 article (01/2004)
9. Allen, John D: 1 article (01/2004)
10. Yao, Denggao: 1 article (01/2004)

Related Diseases

1. Colonic Neoplasms (Colon Cancer)
2. Neoplasms (Cancer)
3. Colorectal Neoplasms (Colorectal Cancer)
4. Lung Neoplasms (Lung Cancer)
5. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. DNA (Deoxyribonucleic Acid)
2. irinotecan (Camptosar)
3. Type I DNA Topoisomerases (Topoisomerase I)
4. Topoisomerase I Inhibitors
5. Uridine Diphosphate (UDP)
6. Tyrosine (L-Tyrosine)
7. Glycoproteins (Glycoprotein)
8. Carrier Proteins (Binding Protein)
9. P-glycoprotein 2
10. trioctyl phosphine oxide (TOPO)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)